Florida Perinatal Quality Collaborative

Located at:

Image

Maternal Opioid Recovery Effort (MORE)

Image



MORE Initiative Overview

 

Urgent Maternal Mortality Message for Providers from Florida PAMR: Overdoses are now the leading cause of pregnancy-associated death in Florida. Obstetric providers, nurses and hospitals are the first health care contact for most mothers with Opioid Use Disorder (OUD) and need to lead the effort to screen, assess, and refer these mothers for OUD treatment.

The rate of pregnant women diagnosed with opioid use disorder (OUD) during labor and delivery in the U.S. more than quadrupled from 1999 to 2014, according to a 2018 analysis by the Centers for Disease Control and Prevention (CDC). In Florida, the rate climbed from 0.5 per 1,000 delivery hospitalizations in 1999 to 6.6 in 2014. 

This project’s purpose is to work with providers, hospitals, and other stakeholders to improve identification, clinical care and coordinated treatment/support for pregnant women with opioid use disorder and their infants.

Project Focus: Standardization related to:

  • OUD Screening
  • Prevention
  • Treatment
  • Comprehensive Discharge Planning

 

Learn about our parallel infant health NAS Initiative.

 





Two Free Buprenorphine CME Training Webinars for OB Providers—1.25 hours of AMA PRA Category 1 Credits

In partnership with Tennessee’s perinatal quality collaborative, FPQC is offering a free CME training on Buprenorphine use in obstetrical practice. The first session describes the basics of Buprenorphine treatment during pregnancy. The second session describes how to make prescribing Buprenorphine in your obstetrical practice work. Both of these sessions with assistance from Florida’s Behavioral Impact Project can help you include in your OB practice. 

A training discussion webinar entitled "Adding Buprenorphine Treatment in Obstetrical Practice: Lessons Learned" was held on January 18th, 2022, and can also help answer additional questions and concerns.